Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children’s Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1

A semiquantitative (123)I-metaiodobenzylguanidine ((123)I-MIBG) scoring method (the Curie score, or CS) was previously examined in the Children’s Oncology Group (COG) high-risk neuroblastoma trial, COG A3973, with a postinduction CS of more than 2 being associated with poor event-free survival (EFS)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Principais autores: Yanik, Gregory A., Parisi, Marguerite T., Naranjo, Arlene, Nadel, Helen, Gelfand, Michael J., Park, Julie R., Ladenstein, Ruth L., Poetschger, Ulrike, Boubaker, Ariane, Valteau-Couanet, Dominique, Lambert, Bieke, Castellani, Maria-Rita, Bar-Sever, Zvi, Oudoux, Aurore, Kaminska, Anna, Kreissman, Susan G., Shulkin, Barry L., Matthay, Katherine K.
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2018
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5868501/
https://ncbi.nlm.nih.gov/pubmed/28887399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.195883
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados